Xingyu Zhou

Xingyu Zhou

Auto-generated profile, based on publicly available information

Xingyu Zhou

Kavli Institute for Astronomy and Astrophysics Peking University Yiheyuan 5 Haidian Qu 100871 Beijing China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2018 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
XZXingyu Zhou
Xingyu Zhou
XWXiaohong Wu
Xiaohong Wu
YCYong Cai
Yong Cai
SCShouchun Cao
Shouchun Cao
XZXiaoping Zhu
Xiaoping Zhu
Rong ZhouRong Zhou
Rong Zhou
The large-scale production of a human diploid cell (HDC) vaccine (HDCV) for rabies is limited by several technical challenges. Kanghua Biological Products Co., Ltd., has successfully used microcarrier technology for the large-scale culture of HDCs in bioreactors to develop a lyophilized and purified HDCV. In this blinded, randomized, parallel-group study conducted between July and October 2014 in Mianzhu, Sichuan Province, China, we monitored the safety and immunogenicity of this vaccine in a healthy population vaccinated according to the Essen post-exposure immunization schedule. A hamster kidney cell vaccine was used as the control. Adverse reactions were monitored 0.5, 6, 24, 48, and 72 h post vaccination to assess safety. Neutralizing antibodies in venous blood were measured on day 7, 14, and 72 to evaluate the immunogenicity of the vaccine while follow-up monitoring continued for 1 month. No serious adverse reactions were observed in any volunteer. The incidence rates of systemic and local adverse reactions were, respectively, 10.6% and 2.9% in the test group and 20.0% and 13.6% in the control group. After the third injection, the positive conversion rates of antibodies in the test and control groups were 100% and 98.82%, respectively. In addition, the average antibody titers on day 7, 14, and 42, were respectively, 1.71, 2.72, and 1.29 times higher than those in the control group. These results indicate that HDCV had a better safety profile and higher immunogenicity than the hamster kidney cell rabies vaccine. Trial registration number: 20130602.

19 September 2022 in arXiv
Verified
Preprint
Open access
PDF file
MKMichael A. Kuhn
Michael A. Kuhn
RSRamzi Saber
Ramzi Saber
MPMatthew S. Povich
Matthew S. Povich
RSRafael S. de Souza
Rafael S. de Souza
AKAlberto Krone-Martins
Alberto Krone-Martins
XZXingyu Zhou
Xingyu Zhou
Wide-field searches for young stellar objects (YSOs) can place useful constraints on the prevalence of clustered versus distributed star formation. The Spitzer/IRAC Candidate YSO (SPICY) catalog is one of the largest compilations of such objects (~120,000 candidates in the Galactic midplane). Many SPICY candidates are spatially clustered, but, perhaps surprisingly, approximately half the candidates appear spatially distributed. To better characterize this unexpected population and confirm its nature, we obtained Palomar/DBSP spectroscopy for 26 of the optically-bright (G<15 mag) "isolated" YSO candidates. We confirm the YSO classifications of all 26 sources based on their positions on the Hertzsprung-Russell diagram, H and Ca II line-emission from over half the sample, and robust detection of infrared excesses. This implies a contamination rate of <10% for SPICY stars that meet our optical selection criteria. Spectral types range from B4 to K3, with A-type stars most common. Spectral energy distributions, diffuse interstellar bands, and Galactic extinction maps indicate moderate to high extinction. Stellar masses range from ~1 to 7 $M_\odot$, and the estimated accretion rates, ranging from $3\times10^{-8}$ to $3\times10^{-7}$ $M_\odot$ yr$^{-1}$, are typical for YSOs in this mass range. The 3D spatial distribution of these stars, based on Gaia astrometry, reveals that the "isolated" YSOs are not evenly distributed in the Solar neighborhood but are concentrated in kpc-scale dusty Galactic structures that also contain the majority of the SPICY YSO clusters. Thus, the processes that produce large Galactic star-forming structures may yield nearly as many distributed as clustered YSOs.